Fragment databases from screened ligands for drug discovery (FDSL-DD)

Area of Science:

• Computational chemistry
• Drug discovery
• Medicinal chemistry

Background:

• Fragment-based drug design (FBDD) is a key computer-aided drug discovery method.
• Traditional FBDD faces challenges including long processing times and limited success rates.

Purpose of the Study:

• To introduce a novel method, Fragment Databases from Screened Ligands Drug Design (FDSL-DD), to enhance FBDD.
• To improve the efficiency and success rate of drug development through intelligent fragment selection.

Main Methods:

• Developed the FDSL-DD method, creating a fragment database from docked, drug-like ligands for specific protein targets.
• Integrated structure-based design screening techniques with FBDD.
• Tested the method on three different protein targets.

Main Results:

• The FDSL-DD method demonstrated increased binding affinity for all tested protein targets.
• A significant improvement of 3.6 kcalmol⁻¹ in binding affinity was observed for a TIPE2 ligand compared to high-throughput virtual screening (HTVS).
• The use of drug-like ligands in initial screening increased chemical space exploration and fragment selection efficiency.

Conclusions:

• The FDSL-DD method offers a more efficient and effective approach to fragment-based drug design.
• This strategy combines the strengths of FBDD and structure-based screening for improved drug candidate identification.
• FDSL-DD shows significant potential for accelerating the drug development process.